Published in Semin Cancer Biol on August 01, 1993
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol (1994) 4.34
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 3.81
Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med (2006) 1.72
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol (1994) 1.64
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. PLoS Biol (2004) 1.44
Discovering the molecular components of intercellular junctions--a historical view. Cold Spring Harb Perspect Biol (2009) 1.39
The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell (2000) 1.26
Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer (1997) 1.25
Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer (2003) 1.09
E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol (2006) 1.03
Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series. Front Oncol (2014) 0.99
Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol Cancer (2014) 0.94
E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway. Acta Pharmacol Sin (2012) 0.89
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers. Virchows Arch (2012) 0.85
Introduction: adhesion molecules in cancer. Part I. Semin Cancer Biol (1993) 0.84
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83
Intracellular domain of desmoglein 3 (pemphigus vulgaris antigen) confers adhesive function on the extracellular domain of E-cadherin without binding catenins. J Cell Biol (1995) 0.82
PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Tumour Biol (2014) 0.81
Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytes. Am J Pathol (2003) 0.79
Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. Elife (2016) 0.79
The role of Sonic Hedgehog as a regulator of gastric function and differentiation. Vitam Horm (2012) 0.77
Identification of genes and signaling pathways associated with squamous cell carcinoma by bioinformatics analysis. Oncol Lett (2015) 0.75
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis (2016) 0.75
The role of E-cadherin/beta-catenin complex and cyclin D1 in head and neck squamous cell carcinoma. Cancer Res Treat (2004) 0.75
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta (1994) 5.81
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol (1994) 4.34
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol (1990) 4.05
Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol (1985) 3.77
Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol (1993) 3.32
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J (1991) 3.20
The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol (2003) 3.06
Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature (1996) 3.00
E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67
Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol (1997) 2.43
Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol (2000) 1.97
Biochemical interactions in the wnt pathway. Biochim Biophys Acta (2000) 1.96
V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift. J Cell Biol (1995) 1.92
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol (1995) 1.91
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene (2008) 1.76
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70
Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development (2001) 1.69
Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol (2000) 1.67
Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer (1991) 1.61
Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene (1995) 1.61
Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res (2001) 1.60
Monoacetoxyscirpenol. A new mycotoxin produced by Fusarium roseum Gibbosum. J Agric Food Chem (1976) 1.55
Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem (2000) 1.50
Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr Opin Cell Biol (1994) 1.48
RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol (1998) 1.39
Iron in prenatal multivitamin/multimineral supplements. Bioavailability. J Reprod Med (1998) 1.38
Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol (2000) 1.34
Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci Suppl (1993) 1.34
Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem (1996) 1.29
The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J Biol Chem (1994) 1.27
Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database Syst Rev (2003) 1.26
Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J Cell Biol (1996) 1.16
Uterotropic activity of cis and trans isomers of zearalenone and zearalenol. Appl Environ Microbiol (1978) 1.13
Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res (1997) 1.10
Effort-reward imbalance and burnout among German nurses in medical compared with psychiatric hospital settings. J Psychiatr Ment Health Nurs (2009) 1.10
Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer (1999) 1.07
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol (2003) 1.05
Substances interfering with the gas-liquid chromatographic determination of T-2 mycotoxin. J Assoc Off Anal Chem (1976) 1.05
A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J Biol Chem (2001) 1.04
The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol Biol Cell (1999) 1.03
Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells. Clin Exp Metastasis (1999) 1.03
Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. J Biol Chem (1996) 1.02
Tyrosine kinase receptors in the control of epithelial growth and morphogenesis during development. Bioessays (1993) 1.02
Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics (1994) 1.01
Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol (1996) 1.01
The Wnt signalling pathway. J Cell Sci (2000) 1.00
Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J Cell Biol (2001) 0.99
Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury. Histochem Cell Biol (1995) 0.99
Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody. J Biol Chem (1990) 0.97
The SH2-containing adapter protein GRB10 interacts with BCR-ABL. Oncogene (1998) 0.97
Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem (1995) 0.96
FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation. Oncogene (1999) 0.95
The role of E-cadherin and scatter factor in tumor invasion and cell motility. EXS (1991) 0.95
Antituberculous therapy and acute liver failure. Lancet (1995) 0.95
Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis. EXS (1993) 0.94
Adherens junction proteins in tumour progression. Cancer Surv (1995) 0.94
Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Mol Carcinog (1997) 0.93
Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett (1997) 0.91
E-cadherin as an invasion suppressor. Ciba Found Symp (1995) 0.90
Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol (1991) 0.90
Kikuchi disease (histiocytic necrotizing lymphadenitis) in association with HTLV1. Br J Dermatol (1997) 0.89
Interaction of the Grb7 adapter protein with Rnd1, a new member of the Rho family. FEBS Lett (2000) 0.86
Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Oncogene (2009) 0.84
Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases. Br J Haematol (1992) 0.82
[Smoking habits of employees and patients in the psychiatric department of a general hospital]. Gesundheitswesen (2004) 0.81
Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. J Biol Chem (2000) 0.80
Response of aplastic anaemia and scleroderma to cyclosporin. Br J Haematol (1993) 0.79
Expression of E-cadherin/catenin complexes in breast cancer. Int J Oncol (1997) 0.78
[Personal contextual factors of the ICF draft from the Working Group "ICF" of Specialty Group II of the Geman Society for Social Medicine and Prevention]. Gesundheitswesen (2010) 0.78
Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fibronectin matrix. A study under the influence of interferon-gamma. J Cell Sci (1993) 0.78
[Intensified rehabilitation aftercare (IRENA): utilization alongside work and changes in work-related parameters]. Rehabilitation (Stuttg) (2011) 0.78
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma. Int J Lab Hematol (2008) 0.77
[Assessment of generic and disease-specific health-related quality of life instruments in peripheral arterial disease]. Vasa (2008) 0.77
[Adherence and cognitive performance in schizophrenia]. Fortschr Neurol Psychiatr (2010) 0.76
[Participant structure of medical rehabilitation measures in Germany]. Rehabilitation (Stuttg) (2011) 0.76
Intramucosal adenocarcinoma of the appendix. Endoscopy (2004) 0.75
[Project "FrühStart"--family midwives in Saxony-Anhalt. Their networking with other health care and child welfare professionals and subjective view of the families]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2010) 0.75
[The amount of professional nursing care in a gerontopsychiatric hospital--comparison of the system of the psychiatry personnel act and the long-term care insurance]. Gesundheitswesen (2009) 0.75
Biomolecular markers of malignancy in human uveal melanoma: the role of the cadherin-catenin complex and gene expression profiling. Ophthalmologica (2003) 0.75
[Personal factors of the ICF]. Gesundheitswesen (2012) 0.75
Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives. Biochemistry (1992) 0.75
Importance of dynamic properties of idiotopes in interactions with anti-Id antibodies. Immunol Invest (1992) 0.75
Before empowerment: residents' memories of the role of the housemother in diaconal residential care settings in Germany 1945-1995. J Psychiatr Ment Health Nurs (2012) 0.75
Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma. Clin Lab Haematol (1997) 0.75
[Quality of life in the focus of quality audits in long-term care]. Gesundheitswesen (2012) 0.75
[Company centredness in the rehabilitation system of the German Democratic Republic, GDR]. Rehabilitation (Stuttg) (2007) 0.75